Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa in newborns with HIE undergoing cooling
NCT01471015Phase 2Completed
- Sponsor
- University of Utah
- Start
- Sep 2012
- Primary completion
- Jan 2014
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of darbepoetin alfa in hypoxic-ischemic encephalopathy (HIE), sponsored by University of Utah. Started Sep 2012; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT01471015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471015.